Solid-state characterization of paclitaxel.

The purpose of this work was to characterize the solid-state properties of anhydrous paclitaxel and paclitaxel dihydrate. Paclitaxel I (anhydrous) was suspended in water for 24 h to convert it to paclitaxel.2H2O. Both forms were analyzed by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). X-ray powder diffraction (XRPD) patterns were obtained at 25, 100, and 195 degrees C. Dissolution profiles of both forms were obtained in water at 37 degrees C over h. DSC of paclitaxel.2H2O showed two endothermic peaks below 100 degrees C, corresponding to dehydration. The resulting solid phase was termed "dehydrated paclitaxel.2H2O". At 168 degrees C, a solid-solid transition was observed in which dehydrated paclitaxel.2H2O was converted to a semicrystalline material called "paclitaxel I/am". The solid-solid transition was followed by melting at 220 degrees C. TGA of paclitaxel.2H2O showed a corresponding biphasic weight loss below 100 degrees C, which was equivalent to the weight of 2 mol of water. DSC of paclitaxel I showed no transitions before melting at 220 degrees C, and no weight loss was observed by TGA. Quenching of paclitaxel I from the melt produced amorphous paclitaxel with a glass transition at 152 degrees C. XRPD confirmed that paclitaxel I, paclitaxel.2H2O, and dehydrated paclitaxel.2H2O had different crystal structures. The X-ray patterns of paclitaxel I and paclitaxel I/am were similar, however the two forms of paclitaxel did not behave identically when analyzed by DSC. The bulk dissolution studies with paclitaxel I showed a rapid increase in concentration to 3 micrograms/mL in 4 h, which decreased to 1 microgram/mL after 12 h, corresponding to the solubility of paclitaxel.2H2O. The solubility of paclitaxel.2H2O was 1 microgram/mL. The data demonstrate the existence of a dihydrate form of paclitaxel that is the stable form in equilibrium with water at 37 degrees C but which dehydrates at temperatures > 45 degrees C.

[1]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[2]  C. Angell,et al.  Strong and Fragile Behavior in Liquid Polymers , 1990 .

[3]  S. Balasubramanian,et al.  Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. , 1995, Journal of pharmaceutical sciences.

[4]  M. R. Mejillano,et al.  Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. , 1992, Journal of medicinal chemistry.

[5]  H. Burt,et al.  Solubility and stability of taxol: effects of buffers and cyclodextrins , 1996 .

[6]  D. Faulds,et al.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. , 1994, Drugs.

[7]  H. Hakusui,et al.  Thermal dehydration of nafagrel hydrochloride hydrate at controlled water vapor partial pressures , 1995 .

[8]  C. Angell,et al.  Liquid fragility and the glass transition in water and aqueous solutions , 1994 .

[9]  D. Kingston,et al.  The chemistry of taxol. , 1991, Pharmacology & therapeutics.

[10]  C. E. Vanderzee,et al.  The influence of grinding stress and thermal annealing on the enthalpy of solution of tris(hydroxymethyl)aminomethane and its use as a test substance in solution calorimetry , 1981 .

[11]  E. Shefter,et al.  DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS. , 1963, Journal of pharmaceutical sciences.

[12]  I. Ringel,et al.  Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations. , 1991, Journal of medicinal chemistry.

[13]  D. Mastropaolo,et al.  Crystal and molecular structure of paclitaxel (taxol). , 1995, Proceedings of the National Academy of Sciences of the United States of America.